Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-14 · accession 0001415889-24-013383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-16 | 2024-05-14 | ELVN | Patel Anish | COO | S - Sale+OE | $25.00 | -1,107 | 0 | -100% | -$27.7K |
| D | 2024-05-16 | 2024-05-14 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +1,107 | 1,107 | New | +$2,745 |
| D | 2024-05-16 | 2024-05-14 | ELVN | Patel Anish | COO | M - OptEx | $0.00 | -1,107 | 54.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | S | D | 1,107 | $25.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-14 | M | A | 1,107 | $2.48 | 1,107 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-05-14 | M | D | 1,107 | $0.00 | 54,475 | D | $2.48 · — to 2031-03-25 | 1,107 Common Stock | (F3) The option, originally for 75,620 shares, vests in 48 equal monthly installments beginning on January 14, 2021. |